Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 7/20 | 0.56 |
| ▸ | SLC6A4 | P31645 | 7/20 | 0.56 |
| ▸ | SLC6A3 | Q01959 | 7/20 | 0.56 |
| ▸ | HRH3 | Q9Y5N1 | 4/20 | 0.54 |
| ▸ | ARG1 | P05089 | 1/20 | 0.45 |
| ▸ | ARG2 | P78540 | 1/20 | 0.45 |
| ▸ | PARP1 | P09874 | 1/20 | 0.41 |
| ▸ | MAOA | P21397 | 1/20 | 0.39 |
| ▸ | MAOB | P27338 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 4/20 | 0.38 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.38 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL440476 | 1.00 | SLC6A2 (0.56) | SLC6A2SLC6A4SLC6A3HRH3ARG1 | |
| SCHEMBL10956783 | 1.00 | SLC6A2 (0.56) | SLC6A2SLC6A4SLC6A3HRH3ARG1 | |
| Hydrochloric Acid SCHEMBL7375378 | 0.98 | SLC6A2 (0.55) | SLC6A2SLC6A4SLC6A3HRH3ARG1 | |
| SCHEMBL7455945 | 0.95 | SLC6A2 (0.52) | SLC6A2SLC6A4SLC6A3HRH3ARG1 | |
| SCHEMBL8083651 | 0.95 | SLC6A2 (0.52) | SLC6A2SLC6A4SLC6A3HRH3ARG1 | |
| SCHEMBL1819249 | 0.91 | SLC6A2 (0.49) | SLC6A2SLC6A4SLC6A3HRH3ARG1 | |
| SCHEMBL1052527 | 0.87 | SLC6A2 (0.54) | SLC6A2SLC6A4SLC6A3HRH3ARG1 | |
| SCHEMBL14828670 | 0.87 | SLC6A2 (0.54) | SLC6A2SLC6A4SLC6A3HRH3ARG1 | |
| SCHEMBL1052525 | 0.87 | SLC6A2 (0.54) | SLC6A2SLC6A4SLC6A3HRH3ARG1 | |
| SCHEMBL11234764 | 0.87 | HRH3 (0.56) | SLC6A2SLC6A4SLC6A3HRH3ARG1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 124 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3914068-A1 | COMPOSITIONS FOR TREATING CITRUS DISEASE AND PROMOTING YIELD INCREASE IN ROW CROPS | Spogen Biotech Inc. (US) | 2021-12-01 | — | — | EP | claimed |
| CN-113395898-A | Compositions for treating citrus disease and promoting yield enhancement of row crops | 斯波根生物技术公司 | 2021-09-14 | — | — | CN | claimed |
| WO-2020154387-A1 | COMPOSITIONS FOR TREATING CITRUS DISEASE AND PROMOTING YIELD INCREASE IN ROW CROPS | SPOGEN BIOTECH INC. (US) | 2020-07-30 | — | — | WO | claimed |
| EP-3606347-A1 | AGRICULTURAL COMPOSITIONS FOR IMPROVED CROP PRODUCTIVITY AND ENHANCED PHENOTYPES | Spogen Biotech Inc. (US) | 2020-02-12 | — | — | EP | claimed |
| CN-109219592-A | Benzyl phenylate analog derivative and its preparation method and pharmaceutical composition and purposes | 中国医学科学院药物研究所 | 2019-01-15 | — | — | CN | claimed |
| WO-2018187345-A1 | AGRICULTURAL COMPOSITIONS FOR IMPROVED CROP PRODUCTIVITY AND ENHANCED PHENOTYPES | SPOGEN BIOTECH INC. (US) | 2018-10-11 | — | — | WO | claimed |
| CN-107417572-A | Benzyl phenylate analog derivative and its preparation method and pharmaceutical composition and purposes | 中国医学科学院药物研究所 | 2017-12-01 | — | — | CN | claimed |
| US-4374131-A | HYPOTENSIVE AGENTS | E. R. SQUIBB & SONS, INC. (US) | 1983-02-15 | — | — | US | claimed |
| EP-0063896-A1 | Amino and substituted amino phosphinyl-alkanoyl compositions | E.R. Squibb & Sons, Inc. (US) | 1982-11-03 | — | — | EP | claimed |
| CN-122055379-A | Compounds containing one or more diboronate esters and related insulin analogues | 普罗托莫科技公司 | 2026-05-15 | — | — | CN | disclosed |
| EP-4694932-A2 | COMPOUNDS CONTAINING ONE OR MORE DIBORONATES AND RELATED INSULIN ANALOGS | Protomer Technologies Inc. (US) | 2026-02-18 | — | — | EP | disclosed |
| EP-4696334-A2 | FIBROBLAST ACTIVATION PROTEIN TARGETED COMPOUNDS AND USE THEREOF | Perspective Therapeutics, Inc. (US) | 2026-02-18 | — | — | EP | disclosed |
| US-12514938-B2 | Fibroblast activation protein targeting peptides | PERSPECTIVE THERAPEUTICS, INC. (US) | 2026-01-06 | — | — | US | disclosed |
| EP-4619043-A1 | FIBROBLAST ACTIVATION PROTEIN TARGETED COMPOUNDS AND USE THEREOF | Perspective Therapeutics, Inc. (US) | 2025-09-24 | — | — | EP | disclosed |
| US-4416831-A | ANGIOTENSIN INHIBITORS | E. R. SQUIBB & SONS, INC. (US) | 1983-11-22 | — | — | US | disclosed |
| US-4374131-A | HYPOTENSIVE AGENTS | E. R. SQUIBB & SONS, INC. (US) | 1983-02-15 | — | — | US | disclosed |
| EP-0063896-A1 | Amino and substituted amino phosphinyl-alkanoyl compositions | E.R. Squibb & Sons, Inc. (US) | 1982-11-03 | — | — | EP | disclosed |
| EP-0052991-A1 | Carboxyalkyl amino acid derivatives of various substituted prolines | E.R. Squibb & Sons, Inc. (US) | 1982-06-02 | — | — | EP | disclosed |
| US-4316905-A | HYPOTENSIVE AGENTS | E. R. SQUIBB & SONS, INC. (US) | 1982-02-23 | — | — | US | disclosed |
| US-4311705-A | HYPOTENSIVE AGENTS | E. R. SQUIBB & SONS, INC. (US) | 1982-01-19 | — | — | US | disclosed |